ARCHIVES

RFPs Available, NIH Funding Strategies

This article is from The Cancer Letter archive.

Vol. 20 No. 07 | February 18, 1994

Download PDF Visit The Full Archive

Related Articles

An old drug’s 21st century makeover begins with 84-fold price increase. Price hike of procarbazine astonishes brain tumor specialists.

May 13, 2005

Decision On Status Of Frederickson, DeVita Due In Month, Schweiker Says

May 1, 1981

AGS-003 Immunotherapy Induces T Cell Responses in Phase II Trial

November 29, 2013

How NCI Plans To Spend Funds In FY 1980

July 14, 1978

NCI-Approved Clinical Trials

July 30, 2010

National Comprehensive Center Network, Quintiles Oncology, To Collaborate On Trials

March 5, 1999